Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.56 |
| ▸ | TSHR | P16473 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.53 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.46 |
| ▸ | HRH3 | Q9Y5N1 | 6/20 | 0.46 |
| ▸ | L3MBTL3 | Q96JM7 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | TACR1 | P25103 | 1/20 | 0.43 |
| ▸ | C3AR1 | Q16581 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4378416 | 0.81 | ALDH1A1 (0.73) | ALDH1A1TSHRKMT2AKDM4EPOLB | |
| SCHEMBL4376335 | 0.80 | ALDH1A1 (0.76) | ALDH1A1TSHRKMT2AKDM4EPOLB | |
| SCHEMBL13636201 | 0.79 | ALDH1A1 (0.63) | ALDH1A1TSHRKMT2AKDM4EHRH3 | |
| SCHEMBL13636497 | 0.78 | NPC1 (0.58) | ALDH1A1TSHRKMT2ANPC1TDP1 | |
| SCHEMBL13636226 | 0.77 | ME2 (0.50) | ALDH1A1KMT2ACHRM1SMN1; SMN2 | |
| SCHEMBL4377238 | 0.75 | KMT2A (0.71) | ALDH1A1TSHRKMT2AKDM4EL3MBTL3 | |
| SCHEMBL4382207 | 0.74 | C3AR1 (0.61) | ALDH1A1TSHRKMT2AKDM4EC3AR1 | |
| SCHEMBL4375187 | 0.74 | KMT2A (0.73) | ALDH1A1TSHRKMT2AL3MBTL3 | |
| SCHEMBL4384086 | 0.74 | C3AR1 (0.62) | ALDH1A1TSHRKMT2AKDM4EC3AR1 | |
| SCHEMBL4383272 | 0.73 | ALDH1A1 (0.98) | ALDH1A1TSHRKMT2AKDM4EL3MBTL3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1421071-B1 | SUBSTITUTED PIPERAZINE AND DIAZEPANE DERIVAIVES AS HISTAMINE H3 RECEPTOR MODULATORS | HIGH POINT PHARMACEUTICALS LLC (US) | 2009-11-18 | — | — | EP | disclosed |